30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Episurf Reports 2Q19 Revenue of SEK 1.1MM (USD $0.1MM), +37.5% vs. 2Q18 -

By Mike Evers, ORTHOWORLD

 

  • Gross order intake for the quarter increased 21% year over year.
  • Orders for the Episealer knee implant increased 14% vs. prior year, with 49 orders.
  • U.S. patient recruitment for the EPIC Knee study is ready to commence.
  • The company received patent approvals in the U.S., Japan and Europe
  • Entered into an agreement with a U.S.-based orthopedic company for use of Episurf’s AI-based imaging tool Epioscopy in allograft surgeries. Details and financial considerations of the agreement are currently confidential.

 

Segment sales and growth on an as-reported basis is as follows ($MM).

  2Q19 2Q18 $ Chg % Chg
Joint Replacement, Knees $0.1 $0.1 $0.0 37.5%
  1H19 1H18 $ Chg % Chg
Joint Replacement, Knees $0.3 $0.2 $0.1 32.8%

 

Sources: Episurf

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.